IL33/TSLP siRNA

N/A

Report date: 2026/04/13 20:02:18
NME

Base Information

Drug NameIL33/TSLP siRNA
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionInterleukin-33 modulatorsThymic stromal lymphopoietin modulators
TargetsInterleukin-33Thymic stromal lymphopoietin
Therapy Area/IndicationsWounds and Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEhime University Graduate School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesEhime University Graduate School Of Medicine
Inactive CompaniesN/A
Active IndicationsWounds and Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A